https://www.selleckchem.com/pr....oducts/beta-lapachon
At the cut-off value 7.2 ng/mL, survival of the 15 patients whose CEA value 7.2 ng/mL was significantly unfavorable compared to those of 57 patients with 7.2 ng/mL Median disease-specific survival time 8.0 versus 24.0 months (P 0.00001). Moreover, the median recurrence-free survival time of the high CEA group was only 5.4 months and there was no 1-year recurrence-free survivor. CEA before NCRT is a crucial prognostic indicator for localized PDAC. Moreover, LAPC with a high CEA level, especially more than 7.2 ng/mL, s
Aimer
Commentaire
Partagez
